<DOC>
	<DOCNO>NCT02264002</DOCNO>
	<brief_summary>Pharmacodynamic effect heart rate ( HR ) rest exercise flicker fusion frequency ( FFF ) , FFF method evaluation Safety , tolerability pharmacokinetics cilobradine</brief_summary>
	<brief_title>Pharmacodynamic Effects , Safety Tolerability Cilobradine , Compared Metoprolol Succinate Placebo Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Metoprolol</mesh_term>
	<criteria>All participant study healthy male female . Volunteers 21 55 year age Body Mass Index ( BMI ) 19.9 29.9 kg/m2 rest heart rate ( HR ) ( 10 min . supine position ) 55 beat per minute ( bpm ) Only postmenopausal female , hysterectomy , could participate . All female negative pregnancy test In accordance good clinical practice ( GCP ) local legislation volunteer give write informed consent prior admission study Any finding medical examination ( include BP , HR ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge Investigator Intake drug long halflife ( &gt; 24 hour ) within ten halflives respective drug enrolment study Use drug might influence result trial within two week prior administration trial Participation another trial investigational drug ( ≤ two month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation ( ≥ 100 ml within four week prior administration trial ) Excessive physical activity ( within last week study ) Any laboratory value outside reference range clinical relevance Not necessarily clinically relevant abnormality , specific Exclusion criterion drug study study : Consumption 2 cup coffee black tea , cola drink , per day last 6 week . However , subject may participate abstinence mention beverage well tolerate interval least 2 week screen first treatment ECG : PQ interval &gt; 210 m HR rest &lt; 55 bpm Systolic BP &lt; 115 mmHg Colour vision test abnormal . However , subject may participate able perform flicker fusion test without difficulty Psoriasis ( medical history relative ) Relevant ophthalmological disease History asthma obstructive pulmonary disease History ( include childhood ) traumatic injury head brain History ( include childhood ) reduce seizure threshold The following subject allow participate study Any subject involve professional transportation human subject Any subject involve operate dangerous machinery</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>